Background: Polydeoxyribonucleotide (PDRN) influencing cellular growth and differentiation is recognized to promote wound healing by stimulating tissue repair. Although PDRN can be extracted from human placentas, PDRN medications have recently been extracted from the semen of trout (Oncorhynchus mykiss) and salmon (Oncorhynchus keta). The present study was designed to evaluate the wound healing effects of O. keta -derived PDRN for injection (Rejuvenex) and PDRN cream (Rejuvenex Cream) in comparison with those of O. mykiss-derived PDRN injection (Placentex). Methods: Full-thickness skin defects were made on the back of mice (n=60). The mice were divided into the following four groups according to the dressing used for the wounds: O. mykiss-derived PDRN injection group, O. keta-derived PDRN injection group, O. ketaderived PDRN cream group, and normal saline soaked dressing group (control group). We analyzed the gross findings, wound sizes, histological findings, immunohistochemistry and enzyme-linked immunosorbent assays for the groups immediately after the treatment, and again after 4, 7, and 10 days of treatment. Results: The wound healing effects were the greatest in the O. keta-derived PDRN injection and O. mykiss-derived PDRN injection groups, which showed similar scores, followed by the O. keta-derived cream and normal saline soaked dressing groups. Conclusion: The injection of PDRN extracted from O. keta was found to be as effective at healing full-thickness skin defects as the O. mykiss-derived PDRN injection, which is currently used in the clinic. Moreover, the O. keta-derived PDRN injection was also found to reduce the time required for wound healing.
INTRODUCTION
Wound healing occurs through multiple stages of coagulation, inflammation, proliferation, and remodeling, which are accompanied by re-epithelialization, contraction, the formation of granulation tissue, and collagen synthesis [1] [2] [3] [4] . Currently, various dressings and treatment methods utilizing diverse substances have been developed in an attempt to treat excisional wounds of the skin. [5, 6] . Such medications are obtained through high-temperature extraction and are characterized by a purity >95% without any additional pharmacologically-active proteins or peptides (Registration Dossier, Italian Ministry of Health) [7] . In terms of the chemical structure, PDRN is composed of low-molecular weight DNA and is a linear polymer comprising 50-2,000 base pairs. PDRN is degraded by active membrane enzymes to serve as a source of purine and pyrimidine deoxynucleosides and deoxyribonucleotides, which increase cellular proliferation and activity in different tissues [8] [9] [10] [11] [12] .
A PDRN injection can be used in the clinical setting to treat wounds, including diabetic foot ulcers. This treatment is already being prepared from the semen of O. mykiss, and is imported from Italy (Placentex Integro, Mastelli, Sanremo, Italy). In South Korea, PDRN has been extracted and purified from the semen of chum salmon (O. keta), which belongs to the same species as O. mykiss and returns to South Korea for spawning; the equivalence of PDRN from difference sources has been confirmed [9, 13] . 
METHODS

Animal models
The experiments were conducted in accordance with the regulations of the Animal Care and Use Committee of Eulji University (No. [13] [14] [15] that oversees animal experiments. Sixty-five of 6-weekold male white ICR (Crl:CD1) mice were used for the experiments.
All mice were kept in a laboratory room with optimized environmental conditions (temperature, 24℃±2℃; humidity, 50%±10%) under a 12 hr/day light cycle. Food and water were available ad libitum. Prior to conducting experiments, the mice were allowed to acclimatize to the environment for at least 1 week.
Materials
Materials are as follows: (1) A total of 10 g of 99% 2.2.2-tribromoethanol (Purum, SigmaAldrich, St. louis, MO, USA) was first mixed into 10 mL of tertamyl alcohol (ReagentPlus, Sigma-Aldrich). This 100% concentration mixture was then mixed with phosphate-buffered saline and diluted to a concentration of 5%. The diluted mixture was then intraperitoneally injected into the 60 mice in the above four treatment groups, excluding those in the no-treatment group, at a dose of 0.006 mL/g for anesthesia. The backs of the mice were subsequently shaved. The back of each mouse was then disinfected with 10% povidone-iodine and 70% ethanol. Using a bovie (Megadyne, Draper, UT, USA), a 1.5×1.5 cm-sized full-thickness skin defect was created, which reached the panniculus carnosus and simulated a full-thickness burn. For dressing, Tegaderm (3M, St. Paul, MN, USA) was attached to the defects of all 15 animals in each group, and Medifoam (Mundipharma, Seoul, Korea) was subsequently fixed using Hypafix (BSN Medical, Hamburg, Germany) tape. The experimental materials were administered to the 15 animals in each group every day during wound healing via an intraperitoneal injection or a topical application at a dose of 8 mg/kg/ day (0.13 mL for injections and 0.3 mL for cream and normal saline).
Methods
Full-thickness skin defects and PDRN procedures
Gross examination and wound size measurement
A Plastic surgeon (J.H.L.) conducted a gross examination and evaluation of the wounds in terms of the skin necrosis, inflammation, and adverse reactions immediately after the treatment, and again after 4, 7, and 10 days of treatment. A sterilized OHP (overhead projector) film was placed on the wound to trace its boundary; the film was then scanned, and the size of the wound was measured using the Image J Version 1.45s software (National Institutes of Health, Bethesda, MD, USA). As a control, a 1.5×1.5 cm-sized square was scanned to measure its size. After converting the measured size to cm 2 , the changes in the size were compared in terms of percentages, where the size measured immediately after the creation of the wound was considered to be 100%. Five animals from each group were sacrificed 4, 7, and 10 days after the creation of wounds. Therefore, on day 4, 15 animals were available for each group; 10 were available in each group on day 7; and five were available on day 10.
Histological examination
Tissues were collected from the sacrificed animals, including the entire wound and surrounding wound tissues. The obtained tissues were fixed for more than 6 hours in 10% formalin. Hematoxylin and eosin staining was subsequently conducted to observe the degree of re-epithelialization, granulation tissue proliferation, necrosis and inflammation, whereas Masson-trichrome staining was conducted to evaluate the formation of collagen. The formation of elastic fibers was used as an index of wound contraction.
The skin tissues were embedded in paraffin and sliced at a thickness of 4-6 µm. Paraffin was removed from the slices using xylene, and the slices were subsequently dehydrated in alcohol. The 
Immunohistochemistry
The tissue samples obtained at 4, 7, and 10 days after wounding were subjected to p63 protein (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) staining to measure the formation of epidermis.
Further, PECAM/CD31 (Santa Cruz Biotechnology) staining was conducted to assess neovascularization. The tissues were then observed under an optic microscope to comparatively evaluate the proliferation of the epidermis.
The mouse tissues were fixed in formaldehyde, and heat-mediated antigen retrieval was conducted using citrate buffer solution.
Subsequently, the samples were blocked for 1 hour in 4% serum at 
Enzyme-linked immunosorbent assays
Tissues were obtained from the sacrificed animals including from the entire wound and surrounding wound tissues, and enzymelinked immunosorbent assays (ELISA) were conducted to measure the vascular endothelial growth factor (VEGF) and transforming growth factor-β (TGF-β) levels. A total of 0.1 g of the skin tissue was homogenized in 150 µL of radioimmunoprecipitation assay lysis buffer containing protease inhibitors (50 mM Tris, pH 8.0; 150 mM NaCl; 1% Triton X-100; 0.5% sodium deoxycholate; 0.1% sodium dodecyl sulfate; 100 mM phenylmethylsulfonyl fluoride; and 1.0 mg aprotinin/mL) and incubated for 30 minutes at 4℃. The sample was then centrifuged at 10,000 ×g at 4℃ for 15 minutes and the supernatant was stored at -70℃ until use.
In order to measure angiogenesis, which exerts a significant influence on wound healing, VEGF mouse ELISA kits (Abcam Inc., Cambridge, MA, USA) were used to compare the various groups.
In order to measure the TGF-β and fibronectin levels, which are considered indicators of inflammation in white mice, TGF-β1 mouse ELISA kits (Abcam Inc.) were used to compare the expression among the experimental groups.
Statistical analysis
Statistical analyses were conducted using the IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA). Tendencies among the data were identified and analyzed using a table where measurements were sorted according to the time, stage, and figure for each group, and are shown as the mean±standard error of the mean.
To compare the changes in wound size observed each day in each treatment group, two-way analysis of variance (ANOVA) was conducted using SPSS, and Bonferroni tests were carried out as 
Using a ×40 magnification optic microscope, 10 fields of view were examined in each tissue slide. The scores for re-epithelialization, granulation tissue proliferation, and inflammation and necrosis observed in the stratum corneum and epithelial layer of the wound were summed; and the sums ranged between -4 and 8, with higher values indicating better wound healing. 
RESULTS
Gross examination
In all experimental groups, the wound healed with time. The wounds healed more rapidly in the PDRN injection and cream groups. When the PDRN-based treatment groups were compared with the control group before the treatment and after 4, 7, and 10 days of treatment, no delayed responses in wound healing, including skin necrosis, inflammation, or other adverse reactions, were seen in any of the groups. In the O. keta-derived PDRN cream group, the topically-applied cream remained on the wound, and the wound thus appeared as if it had impurities and was less clean when compared with that reported for other groups. However, when the cream was removed, wound healing could be seen from inside of the wound (Fig. 1 ).
Wound size measurement
In all PDRN-based treatment groups, the wound size decreased with time. In comparison with that for the control group (normal saline soaked dressing group), the wound size decreased more rapidly in the PDRN injection and cream groups. The differences between each PDRN-based treatment group and the control group on days 4, 7, and 10 were also significant (two-way ANOVA, p<0.05). Post-hoc analyses of the differences between the PDRN treatment groups on different days further indicated that the O.
keta-derived PDRN injection had significantly better wound healing effects than those of normal saline soaked dressing, as evidenced by the changes in wound size observed at all time points (two-way ANOVA, p<0.015). A similar observation was made for Gross findings of the full-thickness wound on the dorsum of the mouse on days 10: the Oncorhynchus mykiss-derived polydeoxyribonucleotide (PDRN) injection group, the Oncorhynchus ketaderived PDRN injection group, the O. keta-derived PDRN cream group, the normal saline soaked dressing group, respectively. There was no delayed wound healing response in all the groups across all time periods. In the O. keta-derived PDRN cream group, the wound appeared as if it had impurities and was less clean when compared with the other groups. However, when the cream was removed, wound healing could be seen from inside of the wound. dressing. However, no statistically significant difference was found among the PDRN-based treatment groups (Fig. 2) .
Histological examination
Hematoxylin and eosin staining
The degree of wound healing was compared using scores that quantified the amount of re-epithelialization, granulation tissue proliferation, and inflammation and necrosis of the wound. All PDRN-based treatment groups were characterized by clear re-epithelialization and granulation tissue proliferation in comparison with that observed for the normal saline soaked group at all time points (days 4, 7, and 10); moreover, the infiltration of inflammatory cells decreased in the PDRN-based treatment groups (Fig. 3) .
Over time, the scores for the degree of wound healing increased in all experimental groups. When the scores were compared, signifi- (Fig. 4 ).
Masson's trichrome staining
No collagen formation was initially observed in any of the groups.
At all time points, pronounced collagen formation was observed in the PDRN-based treatment groups in comparison with that in the normal saline soaked dressing group (Fig. 5) . When the scores for collagen formation were compared, no significant difference was found among the groups on days 4 and 7. On day 4, the scores for collagen formation in all experimental groups were 0. On day 10, collagen formation was observed in all experimental groups, but there were significant differences among them (Kruskal-Wallis test, p<0.05). Post-hoc analyses showed that the collagen formation had increased more significantly in the O. keta-derived PDRN injection group than in the normal saline soaked dressing group (Mann-Whitney test, p<0.05). The effects of the O. keta-derived PDRN cream, which contains less PDRN, were smaller than those of the PDRN injections (Fig. 6 ).
Elastin staining
The formation of elastic fibers was observed in order to measure wound contraction in the collected tissue samples. Although multiple tests were repeated, all experimental groups yielded similar results; at all time points, elastic fiber formation was similarly weak in all experimental groups (Figs. 7, 8) . The expression was the highest in the O. keta-derived PDRN injection and O. mykiss-derived PDRN injection groups, which showed similar levels, followed by the O. keta-derived PDRN cream group and the normal saline soaked dressing group (Fig. 9 ).
CD31
When PECAM/CD31 staining was conducted to evaluate the neovascularization in the collected tissues, no significant differences were observed among the experimental groups at any of the time points. Post-hoc analyses showed that the amount of neovascularization was higher in the PDRN-base treatment groups in comparison with that in the control group on days 7 and 10; however, no statistical significance was noted (Fig. 10 ).
Enzyme-linked immunosorbent assays
Vascular endothelial growth factor
When measurements of angiogenesis, which is crucial for wound healing, were made and compared using VEGF mouse ELISA kits Grade of the epidermal development Day Fig. 9 . The grades of the epidermal development by expression of p63. There were no significant differences on days 4 and 7. However, significant differences between the polydeoxyribonucleotide (PDRN)-based treatment and normal saline soaked dressing groups and between the PDRN injection and PDRN cream groups were seen on day 10. On day 10, the expression was significantly higher in the PDRN injection groups than in the normal saline soaked dressing group. All values are presented as mean±standard deviation from four different independent experimental sets. ing groups at all time points. Nevertheless, no statistically significant difference was observed. VEGF expression in the PDRN injection groups was the highest on day 7 and decreased on day 10.
The expression was the highest in the O. mykiss-derived PDRN injection group, followed by that in the O. keta-derived PDRN injection group, O. keta-derived PDRN cream group, then the normal saline soaked dressing group. Although the increase in VEGF was slower in the O. keta-derived PDRN cream group than in the PDRN injection group, it showed a tendency to increase with time. This is illustrated by the fact that the VEGF expression in this group was higher than that of the normal saline soaked dressing group on day 10 ( Fig. 11) .
Transforming growth factor-β
When measurements of TGF-β and fibronectin, which are indicators of inflammation in white mice, were made using TGF-β1 mouse ELISA kits (Abcam Inc.), significant differences were ob- 
DISCUSSION
Various dressings are being used to treat excisional wounds of the [10, 12, 17, 18] .
PDRN, an A2A receptor agonist, is a polymer in which purine and pyrimidine nucleotides have bonded together through phosphodiester bonds, and is reported to mostly influence nucleotides.
Such nucleotides and nucleosides promote the growth of various cell types while also stimulating the synthesis of nucleic acids and wound healing, by stimulating salvage pathways, which produce nucleic acids at a low energy expenditure, and by activating A2A purinergic receptors [18, 19] .
Studies investigating the safety of PDRN, particularly its acute and chronic toxicity, have confirmed through gross and histological examinations that PDRN does not result in any mortality or have any toxic effect on the liver, lungs, brain, skeletal muscles, or heart [11, 20] . The O. mykiss-derived PDRN injection used in the present study has been clinically approved and is used in Italy as a local and non-oral drug [6] . Several studies have reported that the injection of PDRN promotes the proliferation of human fibroblasts and osteoblasts in in vitro models [8, 9, 12] . In animal experiments, intraperitoneal injections of PDRN were observed to have beneficial effects in a rat model of ischemic skin flaps [21] . Moreover, intraperitoneal injections of PDRN were also used in diabetic mice to stimulate angiogenesis and promote wound healing [10] .
In addition, in mice with deep dermal second-degree burns, intraperitoneal PDRN injections were reported to improve wound
Values of the TGF-β expression (pg) Day   Fig. 12 . The levels of the transforming growth factor-β (TGF-β) expression. There were significant differences among the experimental groups at all time points. The expression of TGF-β was highest in the O. mykiss-derived PDRN injection group, followed by the O. keta-derived polydeoxyribonucleotide (PDRN) injection group, the O. keta-derived PDRN cream group, then the normal saline soaked dressing group. The TGF-β levels were higher in the PDRN-based treatment groups than in the normal saline soaked dressing group at all time points. All values are presented as mean±standard deviation from four different independent experimental sets. Significant differences are indicated by *p<0.02. O, Oncorhynchus.
Normal saline soaked dressing healing [11] . Clinically, wound healing was promoted when PDRN was injected into the muscle and tissues surrounding wounds at skin transplantation donor sites [22] . In patients with pressure sores, injecting PDRN into the muscle and tissues around the sore was reported to promote healing and to decrease the need for additional treatment as well as the length of the hospital stay [20] .
The When the wound healing effects were analyzed 4, 7, and 10 days after the creation of full-thickness skin defect wounds on the backs of ICR mice, the O. keta-derived PDRN injection and PDRN cream were both found to be more effective than normal saline soaked dressing. Moreover, since the wound healing effects of the O. keta-derived PDRN injection did not reveal any significant difference compared to those of the O. mykiss-derived injection, which is currently approved for clinical use, the O. keta-derived PDRN injection is thought to be effective in promoting wound healing for full-thickness skin defects.
However, a limitation of the present study is that it was conducted in animals; in order to apply the findings in the clinical setting, multiple variables regarding wounds, including the size and local condition around the wounds and the systemic condition of the patients, should be considered. Thus, future studies should investigate the mechanisms of action of O. keta-derived PDRN and its safety and efficacy should be evaluated in large randomized clinical trials.
